Laurion Capital Management LP Dexcom Inc Call Options Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $3.31 Million - $5.44 Million	43,800 New	43,800 $5.44 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $66.2 Million - $78.3 Million	637,000 New	637,000 $74 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $8.97 Million - $11.1 Million	117,500 New	117,500 $9.46 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $405,498 - $544,084	-3,800 Reduced 7.06%	50,000 $27.3 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $5.14 Million - $6.08 Million	53,800 New	53,800 $22.2 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.